Skip to main content

Table 8 Change in blood chemistry parameters (kidney function and electrolyte)

From: Matured hop extract reduces body fat in healthy overweight humans: a randomized, double-blind, placebo-controlled parallel group study

Parameter

Sex

Reference range

Group

Ingestion period

Follow-up period

0 w

4 w

8 w

12 w

16 w

UA (mg/dL)

M

3.6-7.0

A

6.37 (0.15)

6.38 (0.17)

6.39 (0.14)

6.43 (0.16)

6.35 (0.16)

P

6.36 (0.17)

6.40 (0.18)

6.58 (0.17)

6.41 (0.18)

6.29 (0.14)

F

2.7-7.0

A

5.09 (0.13)

4.96 (0.14)

5.07 (0.12)

4.98 (0.15)

5.05 (0.13)

P

5.18 (0.14)

5.09 (0.14)

5.18 (0.14)

5.13 (0.14)

5.13 (0.14)

BUN (mg/dL)

 

8.0-20.0

A

13.65 (0.37)

13.58 (0.37)

13.12 (0.38)

12.67 (0.33)**

13.23 (0.30)

P

13.72 (0.35)

13.28 (0.35)

13.31 (0.38)

12.80 (0.30)**

13.32 (0.30)

Cre (mg/dL)

M

0.65-1.09

A

0.816 (0.015)

0.811 (0.014)

0.809 (0.014)

0.791 (0.014)**

0.804 (0.013)

P

0.833 (0.019)

0.828 (0.019)

0.839 (0.020)

0.820 (0.019)

0.826 (0.021)

F

0.46-0.82

A

0.619 (0.014)

0.610 (0.015)

0.618 (0.015)

0.597 (0.013)*

0.619 (0.015)

P

0.629 (0.014)

0.617 (0.013)

0.625 (0.013)

0.606 (0.012)*

0.617 (0.012)

Na (mEq/L)

 

135-145

A

140.5 (0.2)##

140.6 (0.2)

140.5 (0.2)#

140.8 (0.2)

140.6 (0.2)

P

141.3 (0.2)

141.0 (0.2)

141.1 (0.2)

140.9 (0.2)

141.0 (0.2)

Cl (mEq/L)

 

98-108

A

103.9 (0.2)

103.8 (0.2)

104.0 (0.2)

103.8 (0.2)

103.6 (0.2)

P

104.1 (0.2)

104.1 (0.2)

104.2 (0.2)

103.9 (0.2)

103.8 (0.2)

K (mEq/L)

 

3.5-5.0

A

4.18 (0.03)#

4.08 (0.02)**

4.16 (0.03)

4.14 (0.03)

4.18 (0.03)

P

4.11 (0.03)

4.05 (0.03)

4.10 (0.03)

4.11 (0.02)

4.16 (0.02)*

Ca (mg/dL)

 

8.6-10.2

A

9.38 (0.03)

9.37 (0.04)

9.34 (0.04)

9.36 (0.03)

9.39 (0.03)

P

9.41 (0.04)

9.34 (0.04)*

9.40 (0.04)

9.41 (0.04)

9.41 (0.03)

Mg (mg/dL)

 

1.7-2.6

A

2.21 (0.02)

2.21 (0.01)

2.18 (0.01)*

2.19 (0.01)

2.19 (0.01)

P

2.20 (0.02)

2.22 (0.02)

2.21 (0.02)

2.20 (0.02)

2.20 (0.02)

  1. Data are expressed as means (SEM). A, Active group (n = 94); P, Placebo group (n = 94). M, Male; F, Female
  2. # P < 0.05, ## P < 0.01 vs. Placebo group. * P < 0.05, ** P < 0.01 vs. 0 w